| 000 | 01729 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516040816.0 | ||
| 264 | 0 | _c20111020 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1538-7445 | ||
| 024 | 7 |
_a10.1158/0008-5472.CAN-10-3879 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLovly, Christine M | |
| 245 | 0 | 0 |
_aInsights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors. _h[electronic resource] |
| 260 |
_bCancer research _cJul 2011 |
||
| 300 |
_a4920-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnaplastic Lymphoma Kinase |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIsoenzymes |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xchemistry |
| 650 | 0 | 4 |
_aPyridazines _xchemistry |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSirolimus _xpharmacology |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xantagonists & inhibitors |
| 700 | 1 | _aHeuckmann, Johannes M | |
| 700 | 1 | _ade Stanchina, Elisa | |
| 700 | 1 | _aChen, Heidi | |
| 700 | 1 | _aThomas, Roman K | |
| 700 | 1 | _aLiang, Chris | |
| 700 | 1 | _aPao, William | |
| 773 | 0 |
_tCancer research _gvol. 71 _gno. 14 _gp. 4920-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-10-3879 _zAvailable from publisher's website |
| 999 |
_c20874210 _d20874210 |
||